This compound is primarily utilized in the pharmaceutical industry as a chiral intermediate in the synthesis of complex drug molecules. Its structure, featuring a morpholine ring and chiral centers, makes it valuable for producing enantiomerically pure compounds, which are critical in the development of active pharmaceutical ingredients (APIs). It is often employed in the preparation of therapeutic agents targeting neurological disorders, cardiovascular diseases, and infections, where stereochemistry plays a significant role in drug efficacy and safety. Additionally, its tert-butyl and carboxylate groups enhance its stability and reactivity, making it suitable for use in multi-step synthetic routes.